Relmada Therapeutics, Inc. (RLMD) NASDAQ
6.42
-0.43(-6.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.42
-0.43(-6.28%)
Currency In USD
| Market Cap | 190.69M |
| Enterprise Value | 187.19M |
| P/E Ratio | -9.44 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.54 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.25 |
| Return On Equity | -0.71 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -59.1M |
| Net Income | -57.39M |
| Diluted EPS | -1.45 |
| Total Cash | 233.96M |
| Total Cash/Share | 2.7 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 18.26 |
| Book Value Per Share | 2.53 |
| 52-Week Change | 806.14 |
| 52-Week High | 8 |
| 52-Week Low | 0.52 |
| Moving Average 50 Days | 7.09 |
| Moving Average 200 Days | 4.27 |
| Average Volume | 1.9M |
| Shares Outstanding | 73.33M |
| % Held by Institutions | 211.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | September 30, 2019 |